Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 10:23 am Sale |
2025-01-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 2,695,007 2.500% |
-8,426,644 (-75.77%) |
Filing History |
| 2024-11-12 10:32 am Sale |
2024-11-08 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 11,121,651 10.525% |
-336,043 (-2.93%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Intra-Cellular Therapies, Inc. ITCI |
BLACKROCK INC BLK |
6,218,671 5.900% |
0 (Unchanged) |
Filing History |
| 2024-10-24 2:02 pm Sale |
2024-09-30 | 13G | Intra-Cellular Therapies, Inc. ITCI |
BLACKROCK INC BLK |
6,218,671 5.900% |
-1,974,316 (-24.10%) |
Filing History |
| 2024-10-10 12:36 pm Purchase |
2024-09-30 | 13G | Intra-Cellular Therapies, Inc. ITCI |
J P MORGAN CHASE & CO JPM |
5,296,395 5.000% |
5,296,395 (New Position) |
Filing History |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Intra-Cellular Therapies, Inc. ITCI |
The Vanguard Group | 9,094,302 9.450% |
775,053 (+9.32%) |
Filing History |
| 2024-02-09 12:40 pm Sale |
2024-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 3,627,308 3.800% |
-1,112,837 (-23.48%) |
Filing History |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 11,457,694 11.905% |
-571,095 (-4.75%) |
Filing History |
| 2024-02-08 10:14 am Sale |
2023-12-29 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WELLINGTON MANAGEMENT CO LLP | 1,763,475 1.830% |
-3,646,210 (-67.40%) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
BLACKROCK INC BLK |
8,192,987 8.500% |
743,458 (+9.98%) |
Filing History |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Intra-Cellular Therapies, Inc. ITCI |
The Vanguard Group | 8,319,249 8.780% |
1,443,048 (+20.99%) |
Filing History |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 12,028,789 12.701% |
1,066,820 (+9.73%) |
Filing History |
| 2023-02-06 2:53 pm Purchase |
2022-12-30 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WELLINGTON MANAGEMENT CO LLP | 5,409,685 5.710% |
5,409,685 (New Position) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
BLACKROCK INC BLK |
7,449,529 7.900% |
1,727,763 (+30.20%) |
Filing History |
| 2023-01-10 2:38 pm Sale |
2023-01-10 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 4,740,145 5.010% |
-3,495,623 (-42.44%) |
Filing History |
| 2022-02-10 1:38 pm Sale |
2022-02-10 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 8,235,768 10.100% |
-83,444 (-1.00%) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
The Vanguard Group | 6,876,201 8.440% |
394,857 (+6.09%) |
Filing History |
| 2022-02-09 09:19 am Sale |
2022-02-08 | 13G | Intra-Cellular Therapies, Inc. ITCI |
FMR CORP | 10,961,969 13.456% |
-1,061,615 (-8.83%) |
Filing History |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Intra-Cellular Therapies, Inc. ITCI |
BLACKROCK INC BLK |
5,721,766 7.000% |
-176,802 (-3.00%) |
Filing History |
| 2021-12-02 11:31 am Purchase |
2021-12-02 | 13G | Intra-Cellular Therapies, Inc. ITCI |
WASATCH ADVISORS INC | 8,319,212 10.200% |
1,985,312 (+31.34%) |
Filing History |